Your browser doesn't support javascript.
loading
Cariprazine in the treatment of schizophrenia: a proof-of-concept trial.
Durgam, Suresh; Litman, Robert E; Papadakis, Kelly; Li, Dayong; Németh, György; Laszlovszky, István.
Affiliation
  • Durgam S; Departments of aClinical Development bBiostatistics, Forest Research Institute (an Allergan affiliate), Harborside Financial Center, Jersey City, New Jersey cCBH Health LLC, Rockville, Maryland, USA dMedical Division, Gedeon Richter Plc, Budapest, Hungary.
Int Clin Psychopharmacol ; 31(2): 61-8, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26655732
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Schizophrenia / Schizophrenic Psychology / Antipsychotic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2016 Document type: Article Affiliation country: Hungary Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Schizophrenia / Schizophrenic Psychology / Antipsychotic Agents Type of study: Clinical_trials / Diagnostic_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Int Clin Psychopharmacol Journal subject: PSICOFARMACOLOGIA Year: 2016 Document type: Article Affiliation country: Hungary Country of publication: United kingdom